Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate Neuromuscular Blockade in Laparoscopic Gastrectomy
NCT03266419Completed
- Sponsor
- Asan Medical Center
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rocuronium in stomach diseases (2 arms), sponsored by Asan Medical Center. Primary endpoint: Minimum Effective Analgesic Dose of Oxycodone up to 2 hours. Started Mar 2018; status: completed.
02
Drugs
rocuronium
03
Conditions
stomach diseases
Beyond the preview
Go deeper on NCT03266419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03266419.